FDA Taking Steps to Empower Consumers' Use of Nonprescription Drugs

FDA commissioner, Scott Gottleib, released a statement on 7/17/18 discussing new draft guidance related to expanding pathways to OTC drug approval. The new guidance is part of the FDA's efforts to advance a modern framework that is intended to help lower healthcare costs and empower consumers to correctly select drugs that may have previously only been available via prescription.